ライフサイエンスコーパス: angiographic

1 Imaging was performed using angiographic 3 x 3-mm and 6 x 6-mm SS-OCT scans to gener

2 cker in sectors with than in sectors without angiographic abnormalities (421 +/- 102.4 mum vs 397.6 +

3 The observed coronary angiographic abnormalities included tortuosity in all ca

4 However, we observed several coronary FMD angiographic abnormalities with corresponding optical co

5 relationship between choroidal thickness and angiographic abnormalities.

6 o a greater extent in areas characterized by angiographic abnormalities.

7 atment assignment performed a frame-by-frame angiographic analysis in 10,939 patients for the develop

8 Use of CT pulmonary angiographic and admission data from administrative data

9 verolimus-eluting stents because of the best angiographic and clinical outcomes, and DCB because of i

10 The paired MR angiographic and CT angiographic studies also were score

11 e repartition of microspheres was studied by angiographic and histological analyses.

12 ase series describing findings suggestive of angiographic and intracoronary manifestations of coronar

13 Study eye eligibility required angiographic and OCT evidence of choroidal neovasculariz

14 Angiographic and OCT findings were compared with a contr

15 We present angiographic and optical coherence tomography (OCT) find

16 The present study investigated angiographic and optical coherence tomography findings i

17 changes in the retina using volume-rendered angiographic and structural OCT.

18 An independent core laboratory adjudicated angiographic and ultrasound parameters.

19 ow confidence, 4 = absolutely certain) on MR angiographic and UTE images.

20 independent clinical event adjudication and angiographic and wound core laboratories 358 CLI patient

21 ts with information on both CAD (clinical or angiographic) and MI status along with 9p21 genotype.

22 Measure: Epidemiologic, clinical, OCT, AVF, angiographic, and electrophysiological data at baseline

23 were followed-up over 12 months with visual, angiographic, and structural outcomes recorded.

24 1%) decisions, participants relied solely on angiographic appearance that was discordant in 47% with

25 minutes versus 181+/-5 minutes; P=0.67) and angiographic area at risk (24.1+/-1.2% versus 25.3+/-0.9

26 ization based on functional criteria than on angiographic assessment (38.8% versus 62.7%; P=0.015).

27 Angiographic assessment after a median follow-up of 345

28 All of the patients underwent angiographic assessment and perfusion scintigraphy with

29 Angiographic assessment may overestimate disease burden

30 The correlation between angiographic assessment of coronary stenoses and fractio

31 Careful angiographic assessment of individual arteriovenous malf

32 r (the SYNTAX score reflects a comprehensive angiographic assessment of the coronary vasculature, wit

33 been established before and careful OCT and angiographic assessment of this region is warranted.

34 lative to cardiovascular magnetic resonance, angiographic assessment overestimated disease burden at

35 ing the ischemic time, ST-segment elevation, angiographic blush grade, and CFR, IMR has superior clin

36 artery disease (CAD) stratified by detailed angiographic burden of CAD or left ventricular ejection

37 Among subjects with angiographic CAD (n = 20,987), random-effects model iden

38 f prior myocardial infarction, and burden of angiographic CAD (P<0.001), they demonstrated greater ri

39 as associated with outcomes independently of angiographic CAD and modified the effect of early revasc

40 Angiographic CAD extent, defined by degree (no apparent

41 The extent of angiographic CAD is an indicator of post-MI HF regardles

42 t to investigate the impact of sex, CFR, and angiographic CAD severity on adverse cardiovascular even

43 The extent of angiographic CAD was determined at baseline and categori

44 The extent and severity of angiographic CAD were estimated by using the CAD prognos

45 ht to determine the association between CFR, angiographic CAD, and cardiovascular outcomes.

46 or each cohort on the presence and burden of angiographic CAD, MI cases with underlying CAD, and the

47 In a cohort of 1066 angiographic cases and 1011 controls, homozygous carrier

48 Patients with only mild angiographic CAV have significantly better outcomes than

49 The development of any angiographic CAV was also more common in DSA II+ patient

50 l to prasugrel was associated with high-risk angiographic characteristics (thrombotic, long, and bifu

51 This study sought to describe the angiographic characteristics and outcomes in patients pr

52 The angiographic characteristics of SCAD are largely undeter

53 Baseline demographic and angiographic characteristics were also evaluated.

54 echocardiographic, computed tomographic, and angiographic characteristics were retrospectively collec

55 Baseline clinical and angiographic characteristics were similar between the gr

56 investigated occurrence rates, clinical and angiographic characteristics, and possible mechanisms of

57 Thus, we assessed the clinical usefulness, angiographic characteristics, and safety of intracoronar

58 ust for differences in baseline clinical and angiographic characteristics, yielding a total of 326 ma

59 ly pronounced in patients with both of these angiographic characteristics.

60 ICG angiographic CNV surface areas were measured at baseline

61 he SB in-segment diameter stenosis among the angiographic cohort was lower in the bifurcation stent g

62 monstrated a significant interaction between angiographic complexity (as assessed by the SYNTAX score

63 er adjustment for multiple baseline factors, angiographic complexity, and revascularization treatment

64 After angiographic confirmation of ST, OCT imaging of the culp

65 nvited for clinical and computed tomographic angiographic control 1 year after BVS implantation.

66 2- and 3-vessel disease versus those from an angiographic core laboratory analysis.

67 practice versus those made by a centralized angiographic core laboratory.

68 te, or severe) as assessed by an independent angiographic core laboratory.

69 = 0.03) in the subgroup of patients without angiographic coronary artery disease (n = 110) and highe

70 Diabetes mellitus and angiographic coronary artery disease complexity are inte

71 specificities of the 2 techniques to detect angiographic coronary artery disease were similar (McNem

72 Young women, despite having less severe angiographic coronary artery disease, have an increased

73 nclusions and Relevance: Among patients with angiographic coronary disease treated with statins, addi

74 Interventions: Participants with angiographic coronary disease were randomized to receive

75 There was no fluorescein angiographic correlate to these lesions.

76 on spectral-domain OCT, with no fluorescein angiographic correlate.

77 es were compared in groups, with and without angiographic CR, in the PCI and CABG arms.

78 stic regression model for the presence of an angiographic culprit lesion and internally validated wit

79 d for cystoid spaces and integrated into the angiographic data for subsequent volume rendering.

80 d for cystoid spaces and integrated into the angiographic data for subsequent volume rendering.

81 In addition to angiographic data on vascularity and vascular access, de

82 Echocardiographic and angiographic data were evaluated by an independent core

83 revascularization, or missing demographic or angiographic data were excluded.

84 orts A, C, and D (excluding cohort B without angiographic data), the top SNP did not associate signif

85 patients and its pertinence with respect to angiographic data.

86 r by a panel of WISE cardiologists masked to angiographic data.

87 Recurrence, based on angiographic demonstration of leakage, or chronic vascul

88 chronic vascular arrest, confirmed based on angiographic demonstration of peripheral ischemia, was n

89 f an ulcer in the duodenum, the iconic video angiographic depiction as also the therapeutic challenge

90 formed, we compared the respective values of angiographic diameter stenosis (DS) and fractional flow

91 A angioplasty and stenting or DA in terms of angiographic diameter stenosis at 6 months and target le

92 predominant donor vessel FFR correlated with angiographic (%) diameter stenosis severity (r=0.44; P=0

93 Clinical and angiographic differences were noted between the original

94 Angiographic disease burden was determined by the Bypass

95 The extent and severity of angiographic disease were estimated with the use of the

96 ts at high risk of graft loss even with mild angiographic disease.

97 %, P=0.02) compared to patients with minimal angiographic disease.

98 y on intravascular ultrasound, 3 of whom had angiographic disease.

99 Spectral-domain OCT detected all cases of angiographic edema and areas of outer retinal dysfunctio

100 naged nonoperatively (with the assistance of angiographic embolization for 25 patients).

101 ted at the study inclusion after surgical or angiographic embolization to control bleeding (D1), and

102 The secondary angiographic endpoint (powered for superiority) was in-s

103 The primary effectiveness endpoint was angiographic evaluation that demonstrated complete aneur

104 antly cardiac pathogeneses within 9 years of angiographic evaluation.

105 ome (ACS) or stable angina, in whom there is angiographic evidence for obstructive coronary artery di

106 entify the minority of patients with AIS and angiographic evidence of a culprit lesion.

107 Half of all AIS patients had no angiographic evidence of coronary artery disease.

108 556 adult ACS or stable angina patients with angiographic evidence of obstructive coronary artery dis

109 aneous transluminal coronary angioplasty, or angiographic evidence of significant stenosis of the cor

110 An additional preprocedural CC angiographic examination may not be required in TAVR can

111 ithm on radiology reports, each CT pulmonary angiographic examination was classified as positive or n

112 male and female phantoms was observed for CT angiographic examination.

113 nd sustained decrease in use of CT pulmonary angiographic examinations in the evaluation of inpatient

114 onary angiography (26.0 to 22.8 CT pulmonary angiographic examinations per 1000 admissions before and

115 ry angiography or percentage of CT pulmonary angiographic examinations positive for acute PE after CD

116 ngiography yield (percentage of CT pulmonary angiographic examinations that were positive for acute P

117 ve PE diagnoses/total number of CT pulmonary angiographic examinations) was compared in patients in w

118 d, 5287 patients underwent 5892 CT pulmonary angiographic examinations.

119 iable predictors of MI included clinical and angiographic factors (acute coronary syndromes presentat

120 Both clinical and angiographic factors and social determinants of health,

121 cclusion and identification of predictors of angiographic failure after successful chronic total occl

122 ailure in an alternative model that included angiographic failure or death before angiography as the

123 characteristics were analyzed for classical angiographic features (junctions, lengths) wherein we ob

124 t even after adjustment for all clinical and angiographic features (odds ratio: 0.81; 95% confidence

125 however, the association of these SNPs with angiographic features of neovascular AMD has been incons

126 Angiographic features of SCAD are associated with extrac

127 e, predisposing and precipitating stressors, angiographic features, revascularization, use of medicat

128 Late angiographic findings (89.3% of eligible patients), incl

129 In these patients, coronary angiographic findings (excluding dissected segments) wer

130 mbers screened, 58% demonstrated clinical or angiographic findings consistent with stage 1 or 2 FEVR

131 1 or 2 FEVR and 21% demonstrated clinical or angiographic findings consistent with stage 3, 4, or 5 F

132 Angiographic findings in dome-shaped macula suggest the

133 We aimed to investigate coronary angiographic findings in unselected out-of-hospital card

134 Relevant angiographic findings included maximal stenosis and (for

135 We also discussed CT angiographic findings of this case.

136 nrecognized or under-recognized clinical and angiographic findings that are easily identified using w

137 ctrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-

138 FE MR angiographic findings were consistent with correlative p

139 Peripheral angiographic findings, angiographic image acquisition ti

140 On the basis of the CT pulmonary angiographic findings, chromogranin A and 5-hydroxyindol

141 amera appear to correlate well with invasive angiographic findings, including maximal stenosis and FF

142 ata on procedure duration, number of passes, angiographic findings, type of stent retriever used, and

143 Catheter angiography confirmed the CT angiographic findings.

144 compared with DEB, EES provide superior late angiographic findings.

145 esence of discordant stress test results and angiographic findings.

146 ial fat resulted in deep lesions with normal angiographic flow.

147 AD revascularization and had 12- to 18-month angiographic follow-up (n=1539) were included.

148 Patients were scheduled for angiographic follow-up at 6 months, and a subgroup of pa

149 Three-year systematic angiographic follow-up revealed no significant differenc

150 Angiographic follow-up was available for 4975 (84%) of 5

151 minimal lumen diameter at the 6- to 9-month angiographic follow-up.

152 ary outcome was percent diameter stenosis at angiographic follow-up.

153 col treatment included routine 6- to 9-month angiographic follow-up.

154 ic function and filling pressures to augment angiographic grading of cardiac allograft vasculopathy (

155 prevalence gap of 15% or greater between the angiographic groups.

156 rage at 6-month follow-up in comparison with angiographic guidance alone.

157 trut coverage at 6 months in comparison with angiographic guidance only.

158 ng in a larger postprocedure lumen than with angiographic guidance.

159 Peripheral angiographic findings, angiographic image acquisition time, and any complicatio

160 A blinded angiographic image quality assessment was then performed

161 ons in total x-ray energy with no decline in angiographic image quality.

162 the afferent vessel was identified from the angiographic images and marked at the slit lamp using a

163 d to overlay vascular calcification on FE MR angiographic images as composite fused three-dimensional

164 lysis of the OCT B-scans compared to the OCT angiographic images demonstrated that the CNV correspond

165 mistletoe sign on cardiac MR and coronary CT angiographic images is probably rare, but it might be a

166 Capturing of angiographic images took a mean time of 7.09 minutes.

167 ne cardiac cycle and time-of-flight (TOF) MR angiographic images were acquired with a 3-T MR imager.

168 The angiographic images were examined to define the presence

169 The cardiac CT angiographic images were systematically analyzed for ima

170 diography-gated dual-source multidetector CT angiographic images were used from 250 prospectively enr

171 Time-resolved SL MR angiographic images with acquisition window that covered

172 On reconstructed 50-phase CT angiographic images, aortic strain and deformation were

173 fluorescence on late-phase indocyanine green angiographic images.

174 oviders who placed an order for CT pulmonary angiographic imaging about the pretest probability of th

175 With CC angiographic imaging as the reference standard, the accu

176 differences in use and yield of CT pulmonary angiographic imaging before and after CDS.

177 Subsequent angiographic imaging of other vascular beds was negative

178 Time-resolved SL MR angiographic imaging over two cardiac cycles is a reliab

179 Time-resolved SL MR angiographic imaging over two cardiac cycles provided a

180 There was agreement between CT and CC angiographic imaging regarding graft patency in 114 of 1

181 r identifying collaterals are contrast-based angiographic imaging techniques, which are not possible

182 with CT for greater than 70% stenosis at CC angiographic imaging was 100%.

183 source CT system) and coronary catheter (CC) angiographic imaging were retrospectively analyzed.

184 ency in 114 of 115 grafts identified with CC angiographic imaging.

185 However, the adjustment for baseline angiographic imbalances discarded an influence of stent

186 zotarolimus-eluting stent, P=0.75); 13-month angiographic in-stent late lumen loss was 0.22+/-0.41 mm

187 The 13-month angiographic in-stent percent diameter stenosis amounted

188 Angiographic incidence of CAV was 5%, 15%, and 28% at 2,

189 roves reclassification compared with any one angiographic index.

190 diabetics, the relationship between FFR and angiographic indices was particularly weak (C statistics

191 ation, PDT treatment parameters, fluorescein angiographic information, optical coherence tomography (

192 The goal of this study was to compare angiographic interpretation of coronary arteriograms by

193 ntial disagreement and errors in physicians' angiographic interpretation of coronary stenosis severit

194 endoscopy, computed tomographic angiography, angiographic intervention, serial imaging, and clinical

195 chniques such as laparoscopy, endoscopy, and angiographic intervention.

196 The time between angiographic key steps for patients who underwent GA and

197 thout prior revascularization (N = 1,550) by angiographic laboratory investigators masked to patient

198 d group than in the control stent group, and angiographic late loss of the MGuard was consistent with

199 The primary endpoint was angiographic late lumen loss (LLL) at 9 months.

200 o-primary endpoint is the non-inferiority of angiographic late luminal loss.

201 Eyes with baseline fluorescein angiographic leakage were more likely to improve than th

202 Mean total angiographic lesion area changed by -1.15 mm(2), +0.49 m

203 ES/BES) were not superior to BVS in terms of angiographic LLL and clinical outcomes.

204 Between 6 months/1 year and 5 years, angiographic luminal late loss remained unchanged (B1: 0

205 iple studies that had measured the degree of angiographic luminal narrowing in culprit plaques months

206 Angiographic manifestations of coronary FMD aside from d

207 Prespecified angiographic markers of tortuosity including corkscrew a

208 At 1.5 T, all evaluated nonenhanced MR angiographic methods demonstrated satisfactory image qua

209 The final in-stent angiographic minimum lumen diameter was 2.99+/-0.48 mm i

210 Secondary outcomes included final in-stent angiographic minimum lumen diameter, procedure time, and

211 This facilitates angiographic monitoring of embolization at any stage.

212 The incidence of angiographic no reflow (NR) and microvascular obstructio

213 No differences in angiographic or clinical outcomes were observed among pa

214 There were no significant differences in angiographic or OCT findings between BVS and metallic st

215 Binary in-segment restenosis at a 1-year angiographic or ultrasonographic follow-up was the prima

216 yze 1-year clinical and computed tomographic angiographic outcomes after BVS implantation in STEMI.

217 agement strategies and techniques as well as angiographic outcomes and complications related to stent

218 sibility, safety, and promising clinical and angiographic outcomes at 12 months in human coronary art

219 To compare clinical and angiographic outcomes between monitored anesthesia care

220 afe and offers excellent 1-year clinical and angiographic outcomes.

221 trol between groups of diverging clinical or angiographic outcomes.

222 infarct size, myocardial salvage index, and angiographic parameters including myocardial blush grade

223 2 vs. 65.6; IQR: 46.9 to 82.6; p = 0.45), or angiographic parameters such as blush grade (p = 0.63) a

224 The primary end point was 3-year angiographic patency.

225 One-year primary outcome of angiographic percent diameter stenosis was 33.6+/-17.7%

226 rpose To develop a computed tomographic (CT) angiographic postprocessing protocol with two- and three

227 nts of the primary end point and the device, angiographic, procedural, and clinical success rates.

228 Device, angiographic, procedural, and clinical success was achie

229 rate fluid management in patients undergoing angiographic procedures is of critical importance in lim

230 A total of 161 angiographic procedures were performed during the study

231 her SPK (n = 25) or LDK (n = 17), we studied angiographic progression of CAD between baseline (pretra

232 ere imaged with the fluoroscopic tracking MR angiographic protocol.

233 only used clinical musculoskeletal CT and CT angiographic protocols.

234 There was no difference in adjusted angiographic quality score between the cohorts (PR 15, 7

235 s then performed using an objective 10-point angiographic quality score.

236 There was only modest agreement between angiographic readings in clinical practice and those fro

237 Angiographic recanalization prior to PCI was seen in 12

238 results with a very low rate of clinical and angiographic recurrences.

239 The percentage of stent oversizing to angiographic reference vessel diameter (RVD) was calcula

240 received endovascular treatment and achieved angiographic reperfusion (score on Thrombolysis in Cereb

241 Delays in time to angiographic reperfusion lead to a decreased likelihood

242 nclusion in our analysis, 182 (76%) achieved angiographic reperfusion.

243 DS angiographic reports were reviewed for causative abnorma

244 The rate of binary angiographic restenosis was 10.8% and 9.1% in patients a

245 ealed that time from groin puncture to final angiographic result was shorter with patients under GA t

246 The time from groin puncture to the final angiographic result with GA, at 72 minutes (IQR, 45-109

247 roke in the anterior circulation in terms of angiographic results and procedure duration was improved

248 e of the field strength and prior DSA and MR angiographic results and used randomized analysis order)

249 >5 days, overall morbidity and mortality and angiographic results at 1 year.

250 EES provided superior long-term clinical and angiographic results compared with DEB.

251 within 72 hours of symptom onset, initial DS angiographic results negative for aneurysm, and two DSA

252 Angiographic results were excellent without evidence of

253 For magnetic resonance angiographic results, 48% (106 of 221) qualitatively des

254 rformed to identify risk factors (midterm MR angiographic results, aneurysm characteristics, retreatm

255 Immediate angiographic results, primary patient-oriented end point

256 We evaluated 1-year clinical and angiographic results.

257 ascular scaffolds is feasible with excellent angiographic results.

258 ssociated with significantly higher rates of angiographic revascularization at 24 hours (75.8% vs 34.

259 s, functional independence (mRS score, 0-2), angiographic revascularization at 24 hours, symptomatic

260 oved functional outcomes and higher rates of angiographic revascularization, but no significant diffe

261 , predisposing and precipitating conditions, angiographic, revascularization, in-hospital, and long-t

262 y) score has prompted a renewed interest for angiographic risk stratification in patients undergoing

263 derwent a clinical computed tomographic (CT) angiographic runoff examination.

264 Majority had type 2 angiographic SCAD (67.0%), only 29.1% had type 1, and 3.

265 Angiographic SCAD diagnosis was confirmed by 2 experienc

266 -SCAD had fibromuscular dysplasia and type 2 angiographic SCAD.

267 pretreatment and 24-hour magnetic resonance angiographic scans, National Institutes of Health Stroke

268 vents similar to those of subjects with high angiographic scores, and those with low CFR or high CAD

269 These data support the use of angiographic screening and clinical examination in immed

270 Angiographic severity of coronary artery stenosis has hi

271 res were associated with greater severity of angiographic stenosis.

272 Although the classic angiographic "string of beads" that may be observed in r

273 Serial angiographic studies also have demonstrated a sudden rap

274 The paired MR angiographic and CT angiographic studies also were scored for visualization

275 Two readers scored the MR angiographic studies for vessel signal intensity and sha

276 ospective review of 322 computed tomographic angiographic studies that were performed in patients bef

277 he final cohort of 48 336 patients, 58.2% of angiographic studies were classified as appropriate, 10.

278 However, angiographic studies within 3 months before myocardial i

279 ad hoc coil embolization was performed with angiographic success.

280 adverse cardiac events, and 2 (9%) evaluated angiographic success.

281 soconstriction syndrome (RCVS) is a clinical-angiographic syndrome characterized by recurrent thunder

282 1.10 to 1.94), even after adjusting for the angiographic SYNTAX score level.

283 using the Optos Panoramic 200MA fluorescein angiographic system provide a safe and alternative metho

284 rial/Phantom studies were performed with two angiographic systems, FD10 Allura Xper and FD10 Allura C

285 e compared between patients with and without angiographic TCL.

286 Angiographic techniques have been limited by their quali

287 iography (ICGA), and the images from these 3 angiographic techniques were compared.

288 of various endoscopic, imaging, and visceral angiographic techniques.

289 Reperfusion was assessed with angiographic Thrombolysis in Cerebral Infarction scores

290 icipants losing fewer than 15 ETDRS letters, angiographic total lesion size, choroidal neovasculariza

291 ry, presenting characteristics (clinical and angiographic), underlying etiology, management, and card

292 n of coronary artery disease by including 11 angiographic variables that take into consideration lesi

293 sk for graft loss even in children with mild angiographic vasculopathy (p < 0.0001).

294 graft loss even in the presence of only mild angiographic vasculopathy.

295 scaffold versus the Xience metallic stent in angiographic vasomotor reactivity after administration o

296 Outcomes included patient- and graft-level angiographic VGF (>/=75% stenosis or occlusion).

297 One-year angiographic VGF and 5-year rates of death, myocardial i

298 Review of angiographic video in light of operative findings demons

299 [CS] vs general anesthesia [GA]) affects the angiographic workflow applied for treatment of endovascu

300 TA, the influence of the mode of sedation on angiographic workflow during treatment for endovascular